Consent to Examination or Treatment Policy - Nottinghamshire ...

ISSUE 6 – AUGUST 2012 25
Consent to Examination or Treatment – 1.03
given under Section 2. During this period it remains good practice to try and gain the
patient’s consent to treatment.
32.2 Following the three month period, medicines for the treatment of mental disorder can be
given to the patient either with the patient's consent as recorded by the patient's RC on Form
T2 or, in the absence of the patient's consent, only if authorised under a Form T3 completed
by a SOAD. It is the responsibility of the Responsible Clinician to contact the Care Quality
Commission to gain the second opinion; this task will be undertaken by the Mental Health
Act Department if requested by the Responsible Clinician.
33.0 TRAINING
33.1 Training on obtaining consent will be an integral part of the Trust’s Mental Capacity Act and
Mental Health Act training. Scenarios will be used as part of this package to ensure staff
understand the issues involved. Specific training must be given to members of staff
undertaking this delegated task even if they are not authorised to carry out the procedure
themselves.
33.2 Managers will be responsible for identifying staff that need to obtain consent from patients
who are not authorised to carry out the procedures for which consent is being sought .
Directorates will undertake an annual training needs analysis within their area of
responsibility to identify which staff require training and at what level. Reference can be
made to the specific grids through General Managers/ Heads of Service.
34.0 IMPLEMENTATION
34.1 General Managers and Clinical Directors are responsible for ensuring that Consultant
Psychiatrists, the Consultant in Palliative Care and Ward Managers are aware of the
expectations of these principles that they understand the implications of their practice and
that of their staff and for ensuring that all subordinate staff are aware of these principles
35.0 EQUALITY IMPACT ASSESSMENT
35.1 This policy has been assessed using the Equality Impact Assessment Screening Tool. The
assessment concluded that the policy would have no adverse impact on, or result in the
positive discrimination of, any other diverse groups detained. These include the strands of
disability, ethnicity, gender, identify, age, sexual orientation, religion / belief, social inclusion
and community cohesion.
36.0. CONSULTATION
36.1 Executive Leadership Council.
37.0 MONITORING COMPLIANCE
37.1 This policy will be audited annually by Health Partnerships, Local and Forensic Services
Divisions using a ratified audit tool, this will include:
37.2 Evidence of the discussions that have taken place within individual patients and the
information provided as part of obtaining consent.
37..3 How the discussion and provision of information is recorded.
37..4 Evidence relating to the process for recording that consent has been given.
37..5 The process for ensuring that sufficient numbers of staff are trained to obtain consent even if
they are not authorised to conduct the procedure.